Glucocorticoids and outcome of radioactive iodine therapy for Graves' hyperthyroidism

European Journal of Endocrinology

Volumn 153, Issue 1, 2005, Pages 13-14

  Bartalena, Luigi ^a   Tanda, Maria L ^a   Piantanida, Eliana ^a   Lai, Adriana ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; DEXAMETHASONE; GLUCOCORTICOID; LEVOTHYROXINE; PLACEBO; RADIOACTIVE IODINE; REACTIVE OXYGEN METABOLITE; SODIUM IODIDE SYMPORTER; SUPEROXIDE; THYROID ANTIBODY;

ARTICLE; CORTICOSTEROID THERAPY; DISEASE EXACERBATION; DRUG DOSE REGIMEN; DRUG MECHANISM; GRAVES DISEASE; HIGH RISK PATIENT; HUMAN; HYPOTHYROIDISM; PRIORITY JOURNAL; RADIATION INJURY; THYROIDITIS;

COMBINED MODALITY THERAPY; GLUCOCORTICOIDS; GRAVES DISEASE; HUMANS; IODINE RADIOISOTOPES;

EID: 22744432184     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.01938     Document Type: Article

References (15)

1. Cooper DS. Treatment of thyrotoxicosis, In Werner & Ingbar's The Thyroid - a Fundamental and Clinical Text, edn 9, ch 45, pp 665-694. Eds LE Braverman & RD Utiger. Philadelphia, PA: Lippincott Williams & Wilkins, 2005.
2. Bogazzi F, Martino E & Bartalena L. Antithyroid drug treatment prior to radioiodine therapy for Graves' disease: yes or no? Journal of Endocrinological Investigation 2003 26 174-176.
3. Bogazzi F, Bartalena L, Campomori A, Brogioni S, Traino C, De Martino F, Rossi G, Lippi F, Pinchera A & Martino E. Treatment with lithium prevents serum thyroid hormone increase after thionamide withdrawal and radioiodine therapy in patients with Graves' disease. Journal of Clinical Endocrinology and Metabolism 2002 87 4490-4495.
4. Bartalena L, Marcocci C, Bogazzi F, Manetti L, Tanda ML, Dell'Unto E, Bruno-Bossio G, Nardi M, Bartolomei MP, Lepri A, Rossi G, Martino E & Pinchera A. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. New England Journal of Medicine 1998 338 73-78.
5. Bartalena L, Pinchera A & Marcocci C. Management of Graves' ophthalmopathy: reality and perspectives. Endocrine Reviews 2000 21 168-199.
6. Bartalena L, Marcocci C, Bogazzi F, Panicucci M, Lepri A & Pinchera A. Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism. New England Journal of Medicine 1989 321 1349-1352.
7. Jensen BE, Bonnema SJ & Hegedus L. Glucocorticoids do not influence the effect of radioiodine therapy in Graves' disease. European Journal of Endocrinology 2005 153 15-21.
8. Dluhy RG. The adrenal cortex in hypothyroidism. In Werner & Ingbar's The Thyroid - a Fundamental and Clinical Text, edn 9, ch 59, pp 811-816. Eds LE Braverman & RD Utiger. Philadelphia, PA: Lippincott Williams & Wilkins, 2005.
9. Spitzweg C, Joba W, Morris JC & Heufelder AE. Regulation of sodium iodide symporter gene expression in FRTL-5 rat thyroid cells. Thyroid 1999 9 821-830.
10. Scholz IV, Cengic N, Goke B, Morris JC & Spitzweg C. Dexamethasone enhances the cytotoxic effect of radioiodine therapy in prostate cancer cells expressing the sodium iodide symporter. Journal of Clinical Endocrinology and Metabolism 2004 89 1108-1116.
11. Sanner BM, Meder U, Zidek W & Tepel M. Effects of glucocorticoids on generation of reactive oxygen species in platelets. Steroids 2002 67 715-719.
12. Iuchi T, Akaike M, Mitsui T, Ohshima Y, Shintani Y, Azuma H & Matsumoto T. Glucocorticoid excess induces superoxide production in vascular endothelial cells and elicits vascular endothelial dysfunction. Circulation Research 2003 92 81-87.
13. Volk T, Schmutzler M, Engelhardt L, Pantke U, Laule M, Stangl K, Grune T, Wernecke K-D, Konertz W & Kox WJ. Effects of different steroid treatment on reperfusion-associated production of reactive oxygen species and arrhythmias during coronary surgery. Acta Anaesthesiologica Scandinavica 2003 47 667-674.
14. Gamstedt A & Karlsson A. Pretreatment with betamethasone of patients with Graves' disease given radioiodine therapy: thyroid autoantibody response and outcome of therapy. Journal of Clinical Endocrinology and Metabolism 1991 73 125-131.
15. Chiovato L, Fiore E, Vitti P, Rocchi R, Rago T, Dokic D, Latrofa F, Mammoli C, Lippi F, Ceccarelli C & Pinchera A. Outcome of thyroid function in Graves' patients treated with radioiodine: role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damage. Journal of Clinical Endocrinology and Metabolism 1998 83 40-46.